[Appropriate pharmacological therapy after surgical or percutaneous myocardial revascularization]

G Ital Cardiol (Rome). 2010 May;11(5 Suppl 3):116S-120S.

[Article in Italian]

Authors

Pompilio Faggiano¹, Stefania De Feo, Silvia Frattini, Roberto Tramarin, Livio Dei Cas

Affiliation

¹ U.O. di Cardiologia, Spedali Civili, e Cattedra di Cardiologia, Università degli Studi, Brescia. [email protected]

PMID: 20879496

No abstract available

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Angioplasty, Balloon, Coronary
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Coronary Artery Bypass
Drug Therapy, Combination
Evidence-Based Medicine
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Myocardial Ischemia / drug therapy*
Myocardial Ischemia / therapy
Myocardial Revascularization* / methods
Randomized Controlled Trials as Topic
Risk Factors
Treatment Outcome

Substances

Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Anti-Inflammatory Agents, Non-Steroidal
Hydroxymethylglutaryl-CoA Reductase Inhibitors